The munKNEE Pure-Play* Pot Stock Index was UP 2.8% on Monday with 17 of the 25 constituents advancing and 8 declining. 7 went up by more than 5% but none went down by 5% or more. In addition, 2 of the 3 industry categories went up. Details are as follows:

Index Performance

The Index has companies doing business in a number of different categories and sub-categories based on their primary area of focus in the cannabis industry. Those categories are identified below along with the index constituents within each category that went up or down by 5% or more:

1. The Vertically Integrated (i.e. Seed-to-Sale) Category has 22 index constituents that grow, process, and sell cannabis and hemp flower and related products and it went up 2.9%.
   1. The Canadian Licensed Producer (LPs) Category has 7 index constituents and it went up 9.9% with 5 of the 7 going up by 5% or more, namely: 
      1. Aurora (ACB) +17.2% 
      2. Tilray (TLRY) +16.6%
      3. Canopy Growth (CGC) +11.4%
      4. Organigram (OGI) +5.9% and
      5. Cronos (CRON) +5.9%
   2. The U.S. Multi-State Operator (MSOs) Category has 13 index constituents and it went down 0.04% with one stock going up by 5% or more, namely, Acreage (ACRHF) +5.3%
   3. The hemp seed-to-sale MSO sub-category has two index constituents but it had No Change with neither constituent changing price by 5% or more.
2. The Extraction Category has two index constituents focused on the extraction of cannabis compounds and their infusion into consumer products and it went down 2.8% with neither constituent changing price by 5% or more.
3. The Consumption Devices Category has only one index constituent focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers, namely, Greenlane (GNLN), and it went up 5.2%.

*Please note: Each of the 25 pure-play stocks in the munKNEE Pure-Play Pot Stock Index are just that, pure, deriving 100% of their revenue from the sale of recreational and medicinal cannabis and consumption-related products and, as such, the Index reflects the true health of the marijuana industry in the U.S. and Canada. In addition, the Index only includes those pure-play cannabis stocks that consistently trade for more than US$1/share.